ReviewJournal of cardiovascular development and disease2022

Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease.

Juan J Badimon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.